TrialJapanese journal of ophthalmology2026

Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial.

Hideki Koizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.